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Abstract 
Position Effect Variegation (PEV) is the mosaic expression of a gene that has been 
moved out of its optimal environment and into a different area on the chromosome. Changing a 
gene’s environment may have profound effects on its eligibility for proper expression, which is a 
complicated process regulated by many factors. The PEV phenomenon is used as an assay to 
study gene expression as regulated by chromatin structure. In this study, the Drosophila 
melanogaster white gene was used as a reporter to study the various effects of CHD1, a 
chromatin regulating factor, on PEV gene expression. Inspired by preliminary data generated by 
the Armstrong Lab where overexpression of CHD1 resulted in suppression of gene silencing of 
the brown gene and loss of CHD1 resulted in enhancement of gene silencing, this study uses 
PEV as an assay to examine whether loss of function chd1 mutant alleles function dominantly to 
enhance silencing of the white gene when it is placed in a repressive chromatin environment. 
Surprisingly, I found that a chd1 loss of function mutant allele dominantly suppressed gene 
silencing (meaning I saw an increase in gene expression), suggesting that the CHD1 protein is 
normally required for effective silencing. The results demonstrated that CHD1 is a dominant 
modifier of PEV gene expression. CHD1 significantly modifies gene expression by suppressing 
silencing of the white gene inserted into pericentric heterochromatin on the second and fourth 
chromosomes and an insertion into the medial region of the fourth chromosome, while it shows 
no significant modification of the white gene inserted into telomeric heterochromatin of the 
fourth chromosome. Together, these intriguing results regarding varying gene expression at 
different chromosomal sites show that PEV is a dynamic phenomenon meriting further research 
and studying the effects of CHD1 as a modifier of PEV may be influential to understanding the 
mechanism and characteristics of gene expression. 
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Introduction 
Chromatin Structure 
The organization of DNA into chromatin in eukaryote is crucial to gene expression. 
Human cellular DNA measures about two meters long when stretched out but these strands are 
able to fit inside the cell after tight packaging into chromosomes (Alberts et al 2002). To 
condense itself, DNA strands wrap around histone protein octamer that forms nucleosome units 
containing two of each core histones: H2A, H2B, H3, and H4 (Luger 1997). The formation of 
nucleosomes resembles “beads on a string” and can further be compacted (Figure 1). 
Nucleosome-rich regions are tightly compacted and remain condensed throughout the cell cycle; 
they are known as heterochromatin (Heitz 1928).  Heterochromatin are observed to be late 
replicating (Lima de Faria and Jaworka 1968) and are associated with a lack of gene expression 
(Lyon 1961). Other common characteristics of heterochromatin include repetitive DNA 
segments and lack of acetylation modifications (Rea et al. 2000). On the other hand, 
nucleosome-poor regions that are loosely packaged are referred to as euchromatin and are often 
characterized by presence of many acetylated nucleosomes and active genes. Although there are 
exceptions, euchromatin usually consists of active chromatin while heterochromatin consists of 
inactive chromatin.  Heterochromatin may be constitutive, permanently silenced chromatin, or 
facultative, repressed in some cells during specific cycles or developmental stage (Review in 
Allis et al., 2007).   
  
 
Figure 1. Levels of DNA Compaction
DNA strands wrap around histone proteins forming 
string”. The aforementioned structure is considered a loosely packed form of chromatin. The 
“beads-on-a-string” can further be organized into 
through further compaction, the packaged DNA forms chromosome 
Felsenfeld and Groudine 2003). 
 
Chromatin Modifications 
Chromatin is not accessible in the condensed state, therefore covalent 
remodeling modification must occur
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Figure 2. Types of Histone Tail Modifications Modification occurs at the globular domain 
(boxed) as well but histone tails the host majority of known covalent modifications. (Review in 
Vaquero et al 2003) 
In addition to covalent modifications, chromatin remodeling through remodeling factors 
can also make DNA available for transcription. These factors are energy-using protein 
complexes that change chromatin and nucleosome composition in a non-covalent manner. 
Chromatin remodelers are crucial for a number of reasons. First, after replication, nucleosomes 
must be properly deposited and spaced so specialized remodelers are used to correctly position 
the nucleosomes (Review in Vaquero et al 2003). Second, condensed nucleosomes may hide 
important cis elements so remodelers, in this case, can position the cis element in a nucleosome-
free region or in DNA linkers between nucleosomes and also slide the nucleosome to expose cis 
element (Review in Vaquero et al 2003). Third, nucleosomes must be moved or ejected to 
provide quick access for DNA repair and recombination. Lastly, after nucleosomes have been 
moved or ejected, remodelers are needed to move nucleosomes back to its appropriate position 
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(Reviewed in Vaquero et al 2003). Demonstrated in figure 3, chromatin remodelers physically 
change chromatin formation and makes DNA accessible for other processes.  
 
Figure 3. Histone Modifications 
The different outcomes of chromatin remodeling. Remodelers (green) can assist in chromatin 
assembly by moving already deposited histone octamers, generating room for additional 
deposition (a). Remodeler action on a nucleosome array results in various products that can be 
classified in two categories: (b) site exposure, in which a site (red) for a DNA-binding protein 
(DBP), initially occluded by the histone octamer, becomes accessible by nucleosomal sliding 
(repositioning), or nucleosomal eviction (ejection), or localized unwrapping, and (c) altered 
composition, in which the nucleosome content is modified by dimer replacement [exchange of 
H2A-H2B dimer with an alternative dimer containing a histone variant (blue)] or through dimer 
ejection. (Figure from Clapier and Cairns 2009).   
 
There are four families of chromatin remodeling ATPases: ISWI, SNF2, SWR1, and 
CHD (Manning and Peterson, 2013). The remodelers share five basic characteristics: 1) an 
attraction for the nucleosome; 2) domains that recognize covalent histone modifications; 3) a 
conserved ATPase domain that is DNA-dependent; 4) regulators of the ATPase domain; and 5) 
domains and or proteins that allow interactions with other transcription factors (Clapier and 
Cairns, 2009).  Even though the four remodeler families share some common properties, they are 
specialized for different roles when put into biological contexts.   
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One of the more interesting family of chromatin remodelers to me is Chromodomain 
Helicase DNA Binding Protein (CHD), which has been associated with human diseases such as 
prostate cancer (hCHD1), dermatomyositis (hCHD4), Hodgkin’s lymphoma (hCHD3), 
neuroblastoma (hCHD5) and CHARGE syndrome (hCHD7) (Ge Q et al., 1995; Schwab U, 
1982; Thompson PM, 2003; Vissers LE, 2004).   
Of particular interest to my research and the Armstrong lab is CHD1 as studied in 
Drosophila.  Drosophila CHD1 has been found to colocalize with RNA Pol II to sites of active 
transcription on polytene chromosomes (Srivani et al 2005, Marfella et al., 2007). CHD1 also 
plays a crucial role in the pluripotency of mouse embryonic stem cells where mouse stem cells 
lacking CHD1 has high inclination for neuronal differentiation, signifying the loss of capability 
to differentiate into all cell types (Gaspar-Maia et al. 2009). Recent studies have also found that 
human CHD1 is the second most deleted gene in prostate cancer and the deletion increases cell 
invasiveness, suggesting that CHD1 may be required for genetic expression of tumor suppressors 
(Liu et al. 2011, Huang et al. 2011, Burkhardt et al. 2013). Similar to CHD1’s suggestive role as 
a requirement of expression of tumor suppressors, that the loss of CHD1 in clinical specimens 
has been linked to a significant increase in additional chromosomal deletions, both hemi- 
and homozygous, perhaps suggesting that CHD1 is required for regulating DNA processes 
(Liu et al. 2012). With its vast suggestive roles in regulation of DNA and expression of 
genes, along with its  diversity in conservation (Woodage et. al 1997), it is obvious that 
CHD1 plays important roles biologically. It is then necessary that we continue to conduct 
research on this specific chromatin remodeler to better understand its role in DNA organization 
and how that affects gene expression. 
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Position Effect Variegation 
 Position Effect Variegation PEV is an exhibition of mosaic gene expression due to a 
phenomenon where a gene is silenced in some cells yet expressed in others when that gene has 
been moved into a different environment than its norm. In the classic example of PEV, X-Ray is 
used as the mutagen that moved the white gene, usually in euchromatin, into an area closer to 
heterochromatin, resulting in the white gene being turned off in some cells (Muller, 1930). In 
1986, Zhimulev inspected polytene chromosomes of larvae carrying the white rearrangement and 
saw the reporter gene inside a dense block of heterochromatin in all cells where white had been 
silenced (Zhimulev et al., 1986). The fly’s eyes have white patches of cells where white has been 
silenced. The number and size of patches as well as level of pigments differ between flies. 
Because the phenotype is caused by a change in the position of a gene within the chromosome, 
the condition is referred to as Position Effect Variegation. One idea is that virtually any gene in 
the appropriate arrangement can variegate in expression (Allis 2007).   
One of the most well-known explanations for PEV is the spillover model (Talbert and 
Henikoff 2006; Wakimoto 1998), suggesting that rearrangement of chromosome has enabled 
heterochromatin to “spread” and remove a buffer zone that once existed between heterchromatin 
and euchromatin (Locke et al. 1988). With the buffer zone gone, the resulting effect is that  
heterochromatin’s repressive mechanisms (still unknown) spreads over to euchromatin or nearby 
zones and silences genes (Locke et al. 1988). One model suggests that transcription factors fight 
for derepression of heterochromatic silencing (Eissenberg, 2001). The second theory proposed is 
the turnover model, where silencing can be caused due to a loss of epigenetic marks as 
nucleosomes are assembled or histones are exchanged and/or replaced (Yankulov 2012). Some 
suggest PEV is caused by rapid replacement of the H3 histone, which may erase histone marks  
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(Donze et al. 1999, Ishii et al. 2002, Ishii and Laemmlo 2003). In a study in budding yeast, 
activation of promoters is often paired with the eviction of nucleosomes (Boeger et al. 2003) and 
some studies have demonstrated that these activated promoters are sites of H3 histone exchange 
(Dion et. al. 2007; Jamai et al. 2007; Ruflange et al. 2007), suggesting that perhaps with the 
ejection of nucleosomes are placement of histone where ejected nucleosomes were so that 
histones can help arrange for nucleosomes to be in their proper place again. Lastly, an 
explanation supporting the turnover model is that epigenetic marks may be lost during DNA 
replications where the entire genome is subjected to unraveling, chromatin’s role is to preserve 
epigenetic memory by recycling histones so that they can properly manage DNA organization 
(Yankulov 2012).  
This study seeks to combine both the heterochromatin spreading and histone turnover 
theories. I propose that CHD1 antagonizes heterochromatin by preserving epigenetic marks 
through histone recycling and therefore we predict that the loss of CHD1 will result in 
enhancement of gene silencing. Using the PEV phenomenon as an assay to investigate the effects 
of CHD1, a chromatin remodeler, on gene expression at different chromosomal locations, I hope 
to further provide some new perspectives on gene expression in relation to heterochromatin and 
also to provide new clues to understanding human diseases that are affected by PEV. Utilizing 
the white gene as a reporter in my PEV assay, I ask two main questions: 1) does CHD1 
dominantly modifies PEV 2) what is the effect on PEV when both copies of CHD1 is missing in 
the fruit flies.  
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Material and Methods 
Drosophila Stocks 
 Drosophila melanogaster were raised in bottles and vials at 24 °C using standard yeast,  
 
agar, cornmeal and molasses. Flies were taken out of their ideal temperature for no more than 
 
 one hour at a time about every few days for maintenance. 
 
 In examining whether CHD1 dominantly modifies PEV, heterozygous, single-
generational crosses were made using yw as a negative control, al b c sp as a negative control 
and chd1 5 b c sp as the experimental (Appendix). 
 For our negative control, to test the pattern of expression on our PEV lines, Su(var)3-9, a 
suppressor of variegation, was used in single-generation crosses with our four PEV lines 
(Appendix).  
Table 1: Lines of fruit flies used and sources 
Fly Line Source 
w 
1118; 
;	
	
.	
.
;,

; +; + Bloomington Stock Center 
y 1 w*; +; +; 

 !, !"#!
 
Bloomington Stock Center  
ln wm4 ; Su(var) 3-91/ TM3, Sb1 Ser1 Bloomington Stock Center 
w; 
 $%	   '
()*,+,-./,01
 ; +; + Jennifer Armstrong 
w; +; +; 39 C-12 Wallwrath LL and Elgin SC, 1995. 
w; +;+; 118 E-15  Wallwrath LL and Elgin SC, 1995. 
2; 3; 3; 118 6 7 10  Wallwrath LL and Elgin SC, 1995. 
 2; 39 ; 7 4; 3; 3 Wallwrath LL and Elgin SC, 1995. 
2; => ? @ AB ;+; + Frances Wang and Bloomington Stock Center 
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The PEV lines used were gifted by Lori Wallwrath. These fly lines exhibit PEV due to 
the white gene being moved into different chromosomal locations as listed below. 
Table 2: Location of white insertion in the PEV lines (Wallwrath  and Elgin 1995) 
Fly Line Location 
w; 39 C-4; +; + Pericentric, second chromosome 
w; +; +; 39 C-12 Medial, fourth chromosome 
w; +;+; 118 E-15  Telomeric, fourth chromosome 
w; +;+; 118 E-10 Pericentric, fourth chromosome 
 
Preparing Flies for Analysis 
 The progeny of interest were isolated on the thirteenth day after parents have been 
crossed and then kept alive for another six days in order to ensure adult flies of age six-seven 
days. After being aged, they were placed in eppendorf tubes in -20°C freezer for visual and 
quantified analysis of frozen flies within one week. Frances Wang from the Armstrong lab 
conducted an experiment where she found that freezing resulted in reduced level of pigments 
detected via the spectrophotometer; however, it was unclear how long the flies in her experiment 
were frozen for prior to quantification.  
Visualizing Phenotypes 
 Photographs of the eyes of desired progeny were taken using a Nikon Coolpix p6000 
camera attached to a Zeiss WPI Stemi 2000C dissecting microscope. The light arms were angled 
at 45 ° and light intensity at 75% using the Fiber Lite MI 150 High Intensity Illuminator from 
Dolan-Jenner Industries.  The camera setting was set to autofocus, F 6.2 at 1/130 second. The 
flies were turned to their right side.  
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Quantifying Phenotypes 
 Using a razor on the dominant hand and forceps on the non-dominant, fifteen heads were 
obtained for each replicate. The heads were placed in 0.10ml of 99.9% methanol with 0.1% HCl 
then homogenized; then, 0.40 ml of the methanol and HCl solution was added before the 
absorbance was measured. The HCl and methanol were added at different occasions to avoid 
spilling solution and fly heads when the homogenizer  starts. The homogenized mix was 
centrifuged at 10,000 rpm for five minutes. The supernatant was removed and placed in cuvettes. 
Then 0.50 ml of methanol and HCl solution was added to the cuvette and mized up and down 
using a pipette. Absorbance was measured at 480nm using  the Thermo Scientific’s Genesys 10 
Spectrophotometer. 
Results 
In searching for whether CHD1 significantly modifies PEV, I crossed homozygous chd15 
b c sp, al b c sp, yw, and Su(var) 3-91  flies to four PEV lines, resulting in 16 different crosses. 
The yw and al b c sp crosses were used as negative controls, the Su(var) 3-91  was used as a 
positive control and chd1 5 b c sp as the experimental. 
 Spectrum analysis 
Many studies, when measuring expression level of the white gene using the PEV assay, 
measures the absorbance at 480 nm but it was puzzling to me whether the different shades of red 
pigments in the eyes among different PEV lines would affect my absorbance results. I expected 
all four PEV lines with different red-shaded eyes to have different peaks. A spectrum analysis 
where the absorbance was measured at different wavelengths was done.  It was found in this part 
of the study that 480 nm is the peak of the spectrum in three of four PEV lines (all except 39C-
12) and 480 nm is the most consistent wavelength to be used for this experiment (Figure 4). 
  
 
 
Figure 4. Absorbance at different wavelengths.
sp, chd1 b c sp and PEV mutants at different wavelengths. Measured at each point is the mean of 
two biological replicates with a total of 30 male fly heads. Error bars r
(B) Representative visualized phenotype of heterozygous 
Positive control with Su(var)3-91
In the positive control where homozygous 
to each other, I tested to see if the four PEV lines being used react to known modifiers of PEV 
gene expression. I expected the gene expression of the
lines and Su(var) 3-91 to be suppressed (eyes that look more red and higher absorbance level
since Su(var) 3-91  is a  known strong 
Surprisingly, Su(var) 3-91  suppressed silencing only in lines 
39C-4 and 39C-12  (Figure 5).  There were negligible absorbance difference between the control 
and experimental in 39C-4 and 39C
experimental was 16.77 times higher than the control, meaning 
expression of PEV line 118E-15 by 16.77 fold
expression of PEV line 118E-10 by 12.73 fold as absorbance was 12.73 times higher in the 
experimental than in the control progeny (Figure 5
 
 (A) The absorbance of heterozygous 
epresent standard error. 
yw and PEV mutant male flies. 
 
Su(var) 3-91  and the PEV lines were crossed 
 heterozygous progeny of all four PEV 
suppressor of PEV gene silencing (Ner et al 2002)
118E-15 and 118E-
-12 lines (Figure 5A). In the 118E-15 line, absorbance in the 
chd1 modifies the gene 
 (Figure 5A). Similarly, chd1 modifies the gene 
A). The photos taken of the fly eyes of 39C
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yw, al b c 
 
s) 
. 
10 but not  
-4 
  
 
reflect the absorbance data where the eye color did not change between the contro
experimental (Figure 5B). In line 39C
there was a bit higher (but not significant) abs
experimental photo taken is that the control seems to have 
A 
B 
Figure 5. Analysis of suppression of silencing by Su(var)3
heterozygous Su(var)3-9 and PEV mutant flies. Each bar represents the mean absorbance of two 
biological replicates of 30 total male fly heads. 
represents significant difference. (B) Representative visualized phenotype of hete
Su(var)3-9 and PEV mutant male flies. 
 
-12, the photos taken do not reflect absorbance data where 
orbance in the experimental but what is seen in the 
eyes that are more red (Figure 5
-9. (A) Absorbance of 
yw  is control and Su(var) 3-9 is experimental. 
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chd1 dominantly modifies PEV gene expression 
Moving forward after several control experiments, one of the most crucial experiments in 
my study seeks to find whether chd1 dominantly modifies PEV gene expression; that is, when 
there is one copy of chd1 missing on Drosophilas that exhibit PEV, does the white gene get 
expressed more or less, are the variegated eyes more white or more red. If the eyes look more 
white, then the white gene in PEV expression has been more silenced as opposed to if the eyes 
are more red, the white gene has been less silenced/more expressed. There were two controls 
done for this experiment where the first control consisted of crossing homozygous yw to 
homozygous PEV lines to eliminate random elements picked up over time as fruit flies breed 
(Oral fly husbandry process passed down by Professor Armstrong, no literature was found). The 
second control consisted of crossing homozygous al b c sp to the PEV lines to obtain 
heterozygous progenies was to account for the effects of the b c sp markers’ effects on PEV gene 
expression. chd1 is located on the same chromosome as the markers b c sp and this control 
accounts for the PEV gene expression related to these markers. The absorbance of heterozygous 
loss of function chd1 and PEV lines (in orange, Figure 6A) are compared to the second control 
(in green, Figure 6A). I can use the data from this  second control to compare to my experimental 
of heterozygous chd1. Additionally, the body color (yellow and black) seen in the photos of 
figure 6A does not affect gene expression in the eyes.  
Based on a past study by Kelsey Schmidt and Lakshmi Bugga from the Armstrong lab 
using PEV and the brown gene, overexpression of CHD1 resulted in suppression of gene 
silencing of the brown gene and loss of CHD1 resulted in enhancement of gene silencing, I 
hypothesize that the loss of chd1 in my study will result in an enhancement of gene silencing, 
meaning I expected to see flies that have eyes that are more white-looking. Very unexpectedly, 
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three of four PEV lines actually showed that loss of chd1 resulted in significant suppression of 
silencing. The heterozygous progeny of loss of chd1 and PEV lines 39C-4, 39C-12, 118E-10 
resulted in absorbance level that are 2.23, 2.01 and 3.39 times higher than that of the al b c sp 
control, respectively (Figure 6A). The photos presented in figure 6B reflect this change in more 
expression of the white gene and less expression of silencing (eyes look like they have more red 
pigments or look more red overall), although it is difficult to tell by looking that the number of 
red patches have approximately increased by 2.23, 2.01 and 3.39 times. There was no significant 
difference between the heterozygous al b c sp control versus heterozygous chd1 experimental in 
line 118E-15; however, there was a 1.67 time increase in absorbance of the heterozygous  al b c 
sp in comparison to the heterozygous yw (Figure 6A), suggesting the markers b c sp may have 
suppressed PEV gene expression at the telomeric fourth chromosome. The photos from figure 6B 
reflect the increase in absorbance in the al b c sp  compared to the yw progeny because the eyes 
in the heterozygous al b c sp seems to have more red pigments.  
   
 
 
 
 
 
 
 
 
 
  
 
   A                              
 
Figure 6. chd1 dominantly 
modifiesWord did not find any entries 
for your table of contents. PEV gene 
expression in three of four PEV lines.
Four PEV lines were individually 
crossed to homozygous yw, homozygous 
al b c sp, and heterozygous chd1 b c sp
to obtain heterozygous progeny for 
analysis. (A) Each bar contains three 
biological replicates with a total of 45 
male heads. Error bars represent 
standard error. yw is positive control, 
b c sp is positive control and chd1
experimental. * represents significant 
difference. Representative visualized 
phenotype of heterozygous Su(var)3
and PEV mutant male flies. (B) Representative visualize
yw, al bc sp, chd1 b c sp males.  
  
Discussion 
 Multiple theories regarding repressive heterochromatin’s role in PEV gene expression has 
been studied over the years (Yankulov 2013)
whether gene expression is different in var
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affects gene expression at various chromosomal locations using the white gene as a reporter in 
the PEV assay. It was proposed that CHD1 represses heterochromatin spreading by preserving 
epigenetic marks through recycling histones, therefore it was hypothesized that the loss of CHD1 
will result in an enhancement of gene silencing.  
Absorbance was a quantification method used to measure the degree of gene expression 
in different progenies. The absorbance (which was measuring for red pigments at 480 nm) 
corresponded with white gene expression level as seen in PEV. Again, the PEV lines used in this 
study exhibit a variegated eye phenotype because the white gene was moved to various spots on 
different chromosomes and near heterochromatin. The white gene, in a different environment 
than its norm and closer to repressive heterochromatin, is silenced in some cells and expressed in 
others. When comparing negative, positive control and experimental data, higher absorbance 
values were associated with higher white gene expression/suppression of silencing. My results 
were opposite from my hypothesis that loss of CHD1 would result in an enhancement of 
silencing where the white gene was more silenced and the fly eyes would look more white. What 
I found was that CHD1 significantly suppressed gene expression by suppressing silencing of the 
white gene inserted into pericentric heterochromatin on the second and fourth chromosomes and  
white gene insertion into the medial region of the fourth chromosome, while it showed no 
significant modification of the white gene inserted into telomeric heterochromatin of the fourth 
chromosome (Figure 6).  
From the detailed results above, CHD1 is a dominant modifier of PEV gene expression, 
namely at the pericentric left arms second chromosome, pericentric fourth chromosome, and 
medial fourth chromosome (Figure 6). CHD1 does not dominantly modifies at the telomeric 
fourth chromosome (Figure 6) as consistent with a past study where Wallwrath and Elgin found 
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that pericentric and fourth chromosome transgenes, but not telomeric transgenes, respond to 
known suppressors of PEV (Wallwrath and Elgin 1995). Overall, the differences in gene 
expression at different chromosomal sites suggest that various expression mechanisms, not just 
one, are responsible for gene expression, although no previous study further explored this 
puzzling phenomenon. 
Since the results found were opposite to my hypothesis, several other mechanisms can be 
proposed to explain why the loss of CHD1 resulted in suppressed silencing (more white gene 
expression). One, CHD1’s normal role could be a silencer or a factor helping a silencing factor. 
Two, in the loss of CHD1, another remodeling factor may be responsible for histone recycling 
suggesting a perhaps repetitive function in some remodeling factors. Three, with no CHD1 to 
recycle histones, newly-deposited histone may already have the epigenetic marks necessary to 
organize DNA that propagate appropriate gene expression.  
 The results to the second part to my study where I ask whether CHD1 recessively modify 
PEV are not shown in this report because there were not enough progeny to quantify expression 
levels. The necessary flies, both females and males, needed to create homozygous chd1 mutants 
with one copy of a PEV mutant element were very unhealthy due to multiple mutations, making 
it difficult to maintain a sizable stock for experimental crosses. The progeny of “F5” was 
obtained and scored but only 1 male homozygous loss of function chd1 mutant with PEV 
hatched; statistically, in my future studies, at least 750  flies in the “F5” progeny will need to 
hatch  for me to have 15 male flies of desired genotype for each biological replicate.  The flies 
will continue to be bred over many generations until the proper number of flies is obtained for 
quantification. Because only 1 fly of the desired genotype was acquired from the “F5” cross, 
quantification of whether chd1 recessively modifies the white gene in PEV could not be shown. 
  Bui  
 
 
21
My study is currently on “F4” where the cross can be repeated many times using fly siblings to 
grow the stock necessary to make several giant “F5” crosses (See Appendix).  
 In addition, my study also suggests that different PEV lines respond differently to various 
modifiers, supporting that there may be multiple mechanism of gene expression at different 
chromosomal sites.  Using a known suppressor of PEV expression, Su(var)3-9 should have been 
able to suppress all PEV lines used but it was found that this modifier of PEV suppressed 
silencing of the white gene only at the telomeric site of the fourth chromosome and pericentric 
site of the fourth chromosome; it did not suppress silencing at the medial site of the fourth 
chromosome and pericentric site of the second chromosome. These varying results were 
intriguing and supported my previous theory that gene expression is facilitated by different 
mechanisms at different chromosomal sites. It was also puzzling that Su(var)3-9 did not suppress 
gene silencing in line 39C-12  and 39 C-4 where the white gene was moved from euchromatin to 
the medial site of the fourth chromosome because Su(var)3-9  is an established  strong modifier 
of PEV (Ner  et al 2002). The differences in location of suppression suggest that multiple 
mechanisms and/or different protein complexes exist in different areas of the chromosomes; 
these different complexes and mechanisms dictate gene expression that resulted in various PEV 
phenotypes. In the future, further research using more modifiers are necessary to better the 
understanding of the PEV phenomenon and gene expression.  
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Appendix 
Below are individual crosses and expected progenies. The highlighted portion displays 
the progeny desired for optical density quantification. 
Su(var)3-9 modifier crosses-Negative control  
♂ 
0
 C
 ; D
E,F 
  ,    G,
;  3; 3     H    ♀       
0
 0
  ;  3; 3; 
		I J	K 
		I J	K 
 
 
                                                                                ↓ 
 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;  LM
N=O379
1
 
P
; + ; 		I J	K 
P
 
Female, no stubble 
♀   
0
0
 ;  QR3,   L?
1 
LSO
1
P
; + ; 		I J	K 
P
 
Female, stubble 
♂   0
C
 ; LM
N=O379
1
P
; + ; 		I J	K 
P
 
Male, no stubble 
♂   0
C
 ;  R3,   L?
1 
LSO
1
P
; + ; 		I J	K 
P
 
Male, stubble 
 
 
 
 
♂ 
0
 C
 ; D
E,F 
  ,    G,
;  3; 3     H    ♀       
0
  0
  ;  3; 3; 
		I J	T (
		I J	T (
 
 
                                                                                ↓ 
 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;  LM
N=O379
1
 
P
; + ; 		I J	T (
P
 
Female, no stubble 
♀   
0
0
 ;  QR3,   L?
1 
LSO
1
P
; + ; 		I J	T (
P
 
Female, stubble 
♂   0
C
 ; LM
N=O379
1
P
; + ; 		I J	T (
P
 
Male, no stubble 
♂   0
C
 ;  R3,   L?
1 
LSO
1
P
; + ; 		I J	T (
P
 
Male, stubble 
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♂ 
0
 C
 ; D
E,F 
  ,    G,
;  3; 3     H    ♀       
0
  0
  ;  3; 3; 
F(	 	TT
F(	 	TT
 
 
                                                                                ↓ 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;  LM
N=O379
1
 
P
; + ; F(	 	TT
P
 
Female, no stubble 
♀   
0
0
 ;  QR3,   L?
1 
LSO
1
P
; + ; F(	 	TT 
P
 
Female, stubble 
♂   0
C
 ; LM
N=O379
1
P
; + ; F(	 	TT
P
 
Male, no stubble 
♂   0
C
 ;  R3,   L?
1 
LSO
1
P
; + ; F(	 	TT
P
 
Male, stubble 
 
♂ 
0
 C
 ; D
E,F 
  ,    G,
;  3; 3     H    ♀       
0
 0
  ;  
F( UV)  
F( UV)  
;  3; 3 
 
                                                                              ↓ 
 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;  LM
N=O379
1
 
P
; + ; F( UV)  
P
 
Female, no stubble 
♀   
0
0
 ;  QR3,   L?
1 
LSO
1
P
; + ; F( UV)   
P
 
Female, stubble 
♂   0
C
 ; LM
N=O379
1
P
; + ; F( UV)  
P
 
Male, no stubble 
♂   0
C
 ;  R3,   L?
1 
LSO
1
P
; + ; F( UV)  
P
 
Male, stubble 
 
Heterozygous mutant crosses 
 
 
♀  
0
0
;   
 $%	  W X YZ 
()*,+,-./,01
 ; 3; 3  ×  ♂   0
  C
  ;  3; 3; 
		I J	K 
		I J	K 
 
 
                                                                              ↓ 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;  X[\	
  W X YZ
P
; + ; 		I J	K 
P
 
Female, straight wings 
♀   
0
0
 ;  ()*,+,-./,0
1
P
; + ; 		I J	K 
P
 
Female, curly wings 
♂   0
C
 ;  X[\	
  W X YZ
P
; + ; 		I J	K 
P
 
Male, straight wings 
♂   0
C
 ;  ()*,+,-./,0
1
P
; + ; 		I J	K 
P
 
Male, curly wings 
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♀  
0
0
;   
 $%	  W X YZ 
()*,+,-./,01
 ; 3; 3      ×     ♂   0
  C
  ;  3; 3; 
		I J	T (
		I J	T 
 
 
                                                                              ↓ 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;  X[\	
  W X YZ
P
; + ; 		I J	T (
P
 
Female, straight wings 
♀   
0
0
 ;  ()*,+,-./,0
1
P
; + ; 		I J	T (
P
 
Female, curly wings 
♂   0
C
 ;  X[\	
  W X YZ
P
; + ; 		I J	T (
P
 
Male, straight wings 
♂   0
C
 ;  ()*,+,-./,0
1
P
; + ; 		I J	T (
P
 
Male, curly wings 
 
 
 
 
 
 
 
 
 
 
 
 
♀  
0
0
;   
 $%	  W X YZ 
()*,+,-./,01
 ; 3; 3      ×     ♂   0
  C
  ;  
F ( UV)  
F ( UV)   
;  3; 3 
 
    ↓ 
 
 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;  X[\	
  W X YZ
F ( UV)   
; + ; + Female, straight wings 
♀   
0
0
 ;  ()*,+,-./,0
1
F ( UV)   
; + ; 3 Female, curly wings 
♂   0
C
 ;  X[\	
  W X YZ
F ( UV)   
; + ; 3 Male, straight wings 
♂   0
C
 ;  ()*,+,-./,0
1
PF ( UV)   
; + ; 3 Male, curly wings 
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♀  
0
0
;   
 $%	  W X YZ 
()*,+,-./,01
 ; 3; 3      ×     ♂   0
  C
  ;  3; 3; 
F (	  	TT
F (	 	TT
 
 
 
                                                                              ↓ 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;  X[\	
  W X YZ
P
; + ; F (	  	TT
P
 
Female, straight wings 
♀   
0
0
 ;  ()*,+,-./,0
1
P
; + ; F (	  	TT
P
 
Female, curly wings 
♂   0
C
 ;  X[\	
  W X YZ
P
; + ; F (	  	TT
P
 
Male, straight wings 
♂   0
C
 ;  ()*,+,-./,0
1
P
; + ; F (	  	TT
P
 
Male, curly wings 
 
 
Negative control crosses 
 
♀  
0
0
;   
    ' 
    '
 ; 3; 3      ×     ♂   0
  C
  ;  3; 3; 
		I J	K 
		I J	K 
 
 
                                                                          ↓ 
 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;      '
P
; + ; 		I J	K 
P
 
Female 
♂   0
C
 ;     '
P
; + ; 		I J	K 
P
 
Male 
 
 
 
 
♀  
0
0
;   
    ' 
    '
 ; 3; 3      ×     ♂   0
  C
  ;  3; 3; 
		I J	T (
		I J	T (
 
 
                                                                          ↓ 
 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;      '
P
; + ; 		I J	T (
P
 
Female 
♂   0
C
 ;     '
P
; + ; 		I J	T (
P
 
Male 
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♀  
0
0
;   
    ' 
    '
 ; 3; 3      ×     ♂   0
  C
  ;  3; 3; 
F (	 	TT
F (	 	TT
 
 
                                                                          ↓ 
 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;      '
P
; + ; F (	 	TT
P
 
Female 
♂   0
C
 ;     '
P
; + ; F (	 	TT
P
 
Male 
 
 
 
 
 
 
♀  
0
0
;   
    ' 
    '
 ; 3; 3      ×     ♂   0
  C
  ;  
F ( UV)    
F ( UV)  
;  3; 3 
 
                                                                          ↓ 
 
 
Expected Progeny Genotype Expected Phenotype 
♀   
0
0
 ;      '
F ( UV)   
; + ; + Female 
♂   0
C
 ;     '
F ( UV)   
; + ; + Male 
 
 
Negative control crosses 
 
♀  
)0
)0
;  3; 3; 3      ×     ♂   0
  C
  ;  3; 3; 
		I J	K 
		I J	K 
 
 
                                                                                                   ↓ 
 
 
Expected Progeny Genotype Expected Phenotype 
♀   
)0
0
 ; +; + ; 		I J	K 
P
 
Female 
♂   )0
C
 ; +  ; + ; 		I J	K 
P
 
Male 
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♀  
)0
)0
;  3; 3; 3      ×     ♂   0
  C
  ;  3; 3; 
F (	 	TT
F (	 	TT
 
                                                                                                
        ↓ 
 
 
Expected Progeny Genotype Expected Phenotype 
♀   
)0
0
 ; +; + ; F (	 	TT
P
 
Female 
♂   )0
C
 ;+; + ; F (	 	TT
P
 
Male 
 
 
 
 
 
 
♀  
)0
)0
;  3; 3; 3      ×     ♂   0
  C
  ;
F ( UV)  
F ( UV)  
;   3; 3 
                                                                                                 
         ↓ 
 
 
 
Expected Progeny Genotype Expected Phenotype 
♀   
)0
0
 ; +; + ; F ( UV)  
P
 
Female 
♂   )0
C
 ;+; + ; F ( UV)  
P
 
Male 
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“Four” generation of crosses to obtain progenies with homozygous chd1 mutants and a 
PEV affected gene. Labeled as four generations to keep track, but in reality “F3” has to be 
repeated multiple times to have enough virgin progeny to start F4.  
 
F1 ♀  0
]
0]
 ; 
;	
	
.	
.
;,

; +; +      ×       ♂ )
0^
C
 
; +; +; 
_` !, !"#!
 
 
 
     ↓ 
 
 
Expected Progeny Genotype Expected Phenotype 
 
♂ 
0]
C
; P
;,

 ; +; _`
 !, !"#!
P
 
 
Male, tubby body, 
unorganized eye 
pattern, missing end 
part of third vein  
 
♂
0]
C
; P
;,

 ; +; 

P
 
 
Male, tubby body, 
unorganized eyes 
 
♂ 
0]
C
;  
P
aZ;	
	
.	
.
 ; +; _`
 !, !"#!
P
 
 
Male, normal size 
body, missing end part 
of third vein 
 
♂ 
0]
C
; ; P
aZ;	
	
.	
.
 ; +; 

P
 
 
Male, normal size body 
 
♀ 
0]
)0^
; P
;,

 ; +; _`
 !, !"#!
P
 
 
Female, tubby body, 
unorganized eyes, 
missing end part of 
third vein 
 
♀ 
0]
)0^
; P
;,

 ; +; 

P
 
 
Female, tubby body, 
unorganized eyes 
 
♀ 
0]
)0^
; P
aZ;	
	
.	
.
 ; +; _`
 !, !"#!
P
 
 
Female, normal size 
body, unorganized 
eyes, missing end part 
of third vein 
 
♀ 
0]
)0^
; P
aZ;	
	
.	
.
 ; +; 

P
 
Female, normal size 
body 
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F2♀0
0
 ;  $%	
   '
()*,+,-./,01
 ; +; +                ×       ♂ 0
C
; P
;,

 ; +; _`
 !, !"#!
P
 
 
 ↓ 
 
Expected Progeny Genotype Expected Phenotype 
♀ 
0
0
;  $%	
    ',P
;,

 ; + ; P
_` !, !"#!
     
Female, tubby body, 
missing end of third 
vein, white eye, 
disorganized eye 
pattern  
♀ 
0
0
;  $%	
    ',P
P
 ; + ; P
_` !, !"#!
     
Female, white eye, 
straight winged, 
missing end part of 
third vein 
♀ 
0
0
;  $%	
    ',P
;,

 ; + ;+ Female, white eye,  
tubby body, curly 
wings, unorganized eye 
pattern 
♀ 
0
0
;  $%	
    ',P
P
 ; + ; 3 Female, white eye, 
straight wings 
♀ 
0
0
; (*,+,-./,0
1
;,

 ; + ; P
_` !, !"#!
     
Female, curly wings, 
red eyes, tubby body, 
unorganized eye 
pattern, missing end of 
third vein, disorganized 
pattern of eye 
♀ 

0
; ()*,+,-./,0
1
P
 ; + ; P
_` !, !"#!
     
Female, red eye, curly 
wings, missing end part 
of third vein 
♀ 
0
0
; ()*,+,-./,0
1
;,

 ; + ;+ Female, red eye,  tubby 
body, curly wings, 
unorganized eye pattern 
♀ 
0
0
; ()*,+,-./,0
1
P
 ; + ; 3 Female, red  eye, curly  
wings 
♂ 
0
C
;  $%	
    ',P
;,

 ; + ; P
_` !, !"#!
     
Male, tubby body, 
missing end of third 
vein, white eye, 
disorganized eye 
pattern 
♂ 
0
C
;  $%	
    ',P
P
 ; + ; P
_` !, !"#!
     
Male, white eye, 
straight winged, 
missing end part of 
third vein 
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♂ 
0
C
;  $%	
    ',P
;,

 ; + ;+ Male, white eye,  tubby 
body, curly wings, 
unorganized eye pattern 
♂ 
0
C
;  $%	
    ',P
P
 ; + ; 3 Male, white eye, 
straight wings 
♂ 
0
C
; ()*,+,-./,0
1
;,

 ; + ; P
_` !, !"#!
     
Male, curly wings, red 
eyes, tubby body, 
unorganized eye 
pattern, missing end of 
third vein, disorganized 
pattern of eye 
♂ 
0
C
; ()*,+,-./,0
1
P
 ; + ; P
_` !, !"#!
     
Male, red eye, curly 
wings, missing end part 
of third vein 
♂ 
0
C
; ()*,+,-./,0
1
;,

 ; + ;+ Male, red eye,  tubby 
body, curly wings, 
unorganized eye pattern 
♂ 
0
C
; ()*,+,-./,0
1
P
 ; + ; 3 Male, red  eye, curly  
wings 
 
This first part of the third generation of crosses seeks to breed a semi-stable stock. Each  
 
generation, the progeny with all expected phenotype characteristics must be selected to breed the  
 
next generation. Half of the progeny loses the dominant ci marker every generation so selective  
 
breeding occurs to produce more desired flies for more “F3” stock and F4 crosses. 
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F3♀  0
0
;  $%	
    ',P
;,

 ; + ; P
_` , !"#!
    ×     ♂  
0
C
;  $%	
    ',P
;,

 ; + ; P
_` !, !"#!
 
 
 
   ↓ 
 
Expected Progeny Genotype Expected Phenotype 
♀  
0
0
;  $%	
    ',P
;,

 ; + ; P
_` !, !"#!
 
Female, white eye, 
tubby body, 
unorganized eye 
pattern, missing end 
part of third vein 
♀  
0
0
;  $%	
    ',P
;,

 ; + ; 3 Female, full veins 
 ♂  
0
C
;  $%	
    ',P
;,

 ; + ; P
_` !, !"#!
 
Male, white eye, tubby 
body, unorganized eye 
pattern, missing end 
part of third vein 
♂  
0
C
;  $%	
    ',P
;,

 ; + ; 3 Male, full veins 
 
 
 
 
 
 
 
 
F3♀ 0
0
;  $%	
    ',P
;,

 ; + ; P
_` !, !"#!  
     H    ♂
0
C
; +; +; F (	 	TT
F (	 	TT
  
 
 
                    ↓ 
 
Expected Progeny Genotype Expected Phenotype 
♀  
0
0
;  $%	
    ',P
P
 ; + ; 39 ;712 1020
_` !, !"#!
 
Female, white eyes, 
missing last part of third 
vein 
♀  
0
0
;  $%	
    ',P
P
 ; + ; 39 ;712 1020
P
 
Female, white eyes 
♀  
0
0
;  Q
2;3LR6?7QR6d,=BefQ?
1
 
P
 ; + ; 39 ;712 1020
P
 
Female, white eyes, tubby 
body, unorganized eye 
pattern 
♀  
0
0
;  Q
2;3LR6?7QR6d,=BefQ?
1
 
P
 ; + ; 39 ;712 1020
ln4@i
j
,@i
j
B=k@ij  
 
Female, white eyes, 
missing last part of third 
vein, tubby body, 
unorganized eye pattern 
♂  
0
C
;  $%	
    ',P
P
 ; + ; PF (	 	TT
_` ! , !"#!
 
 
Male, white eyes, missing 
last part of third vein 
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♂  
0
C
;  $%	
    ',P
P
 ; + ; P
F l 	TT
 
Male, white eyes, tubby 
body, unorganized eye 
pattern 
♂  
0
C
; P
;,

 ; + ; F (	 	TT
_` !, !"#!
 Male, white eyes, missing 
last part of third vein, 
tubby body, unorganized 
eye pattern 
♂  
0
C
; P
;,

 ; + ; P
F l	 	TT
 Male, white eyes, tubby 
body, unorganized eye 
pattern 
 
 
The fourth generation of crosses consists of crossing desired chd1 mutant flies from F3 with the 
three PEV lines. 
 
F4 to obtain homozygous chd1 mutant with one mutant copy of 39 C-12 1020 
 
 ♀  
0
0
;  $%	
    ',P
;,

 ; + ; P
_` !, !"#!
    H  ♂ 
0
C
;  $%	
   '
P
;+; F (	 	TT
_` !, !"#!
 
 
 
 
   ↓ 
 
 
Expected Progeny Genotype Expected Phenotype 
♀  
0
0
;  $%	
    ',P
 $%	    ',PP
 ; + ; 39 ;712 1020
P
 
Female, black body, 
curved wings, full 
veins 
♀  
0
0
;  $%	
    ',P
 $%	    ',PP
 ; + ; 3
ln4@ij,@ijB=k@ij
 
Female, missing end 
part of third vein, 
curved wings, black 
body, straight wings 
♀  
0
0
;  $%	
    ',P
 $%	    ',PP
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 Female, lethal 
♀  
0
0
;  $%	
    ',P
3
 ; + ; 39 ;712 1020
ln4@ij,@ijB=k@ij
 Female, straight wings, 
red eyes, missing end 
part of third vein 
♀  
0
0
;  $%	
    ',P
3
 ; + ; 39 ;712 1020
P
 Female, straight wings, 
full veins  
♀  
0
0
;  $%	
    ',P
3
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Female, lethal 
♀  
0
0
;  $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
39 ;712 1020
ln4@ij,@ijB=k@ij
 Female, tubby body, 
unorganized eye 
pattern, missing end 
part of third vein, curly 
wings 
  Bui  
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♀  
0
0
;  $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
3
ln4@ij,@ijB=k@ij
 
 
Female, tubby body, 
missing end part of 
third vein, tubby body, 
unorganized eye patter 
♀  
0
0
;  $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
ln4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
 
Female, lethal 
♀  
0
0
;  Q
2;3LR6?7QR6d,=BefQ?
1
 
P
 ; + ; 39 ;712 1020
P
 
Female, tubby body, 
unorganized eye 
pattern, full veins 
♀  
0
0
; Q
2;3LR6?7QR6d,=BefQ?
1
P
 ; + ; 39 ;712 1020
ln4@ij,@ijB=k@ij
 
Female, tubby body, 
unorganized eye 
pattern, curly wings, 
missing end part of 
third vein  
♀  
0
0
; Q
2;3LR6?7QR6d,=BefQ?
1
P
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Female, lethal 
♂  
0
C
;   $%	
    ',P
 $%	    ',PP
 ; + ; 39 ;712 1020
P
 
Male, black body,  
curved wings, full 
veins 
♂  
0
C
;   $%	
    ',P
 $%	    ',PP
 ; + ; 3
ln4@ij,@ijB=k@ij
 
Male, missing last part 
of third vein, black 
body, curved wings 
♂  
0
C
;  
 $%	    ',P
 $%	    ',PP
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Male, lethal 
♂ 
0
C
;   $%	
    ',P
3
 ; + ; 39 ;712 1020
ln4@ij,@ijB=k@ij
 
Male, missing end part 
of third vein, straight 
wings 
♂  
0
C
;   $%	
    ',P
3
 ; + ; 39 ;712 1020
P
 
Male, no black body, 
no curved wings, full 
veins 
♂  
0
C
;   $%	
    ',P
3
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Male, lethal 
♂  
0
C
;   Q
2;3LR6?7QR6d,=BefQ?
1
 
P
 ; + ; 39 ;712 1020
P
 
Male, tubby body, 
unorganized eye 
pattern, straight wings 
♂  
0
C
; Q
2;3LR6?7QR6d,=BefQ?
1
3
 ; + ; 39 ;712 1020
ln4@ij,@ijB=k@ij
 
Male, red eyes, tubby 
body, unorganized eye 
pattern curly wings, 
missing end part of 
third vein 
♂  
0
C
; Q
2;3LR6?7QR6d,=BefQ?
1
3
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Male, lethal 
♂  
0
C
;   $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
39 ;712 1020
ln4@ij,@ijB=k@ij
 
Male, tubby body, 
unorganized eye 
pattern, curly wings, 
missing last part of 
third vein 
  Bui  
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♂  
0
C
;  
 $%	    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
3
ln4@ij,@ijB=k@ij
 
 
Male, missing end part 
of third vein, tubby 
body, unorganized eye 
pattern, curly wings 
♂  
0
C
;   $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
ln4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
 
Male, lethal 
 
 
 
 
F4 to obtain homozygous chd1 mutant with one copy of mutant 118 E-15 T4 
 
 
 
♀  
0
0
;  $%	
    ',P
;,

 ; + ; P
_` !, !"#!
    H  ♂ 
0
C
;  $%	
   '
()*,+,-./,01
;+; 		I J	K 
_` !, !"#!
 
 
 
 
   ↓ 
 
 
 
 
Expected Progeny Genotype Expected Phenotype 
♀  
0
0
;  $%	
    ',P
 $%	    ',PP
 ; + ; 3118 6715 Q4
P
 
Female, black body, 
curved wings, full 
veins 
♀  
0
0
;  $%	
    ',P
 $%	    ',PP
 ; + ; 3
ln4@ij,@ijB=k@ij
 
Female, missing end 
part of third vein, 
curved wings, black 
body, straight wings 
♀  
0
0
;  $%	
    ',P
 $%	    ',PP
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 Female, lethal 
♀  
0
0
;  $%	
    ',P
3
 ; + ; 118 6715 Q4
ln4@ij,@ijB=k@ij
 Female, straight wings, 
red eyes, missing end 
part of third vein 
♀  
0
0
;  $%	
    ',P
3
 ; + ; 118 6715 Q4
P
 Female, straight wings, 
full veins  
♀  
0
0
;  $%	
    ',P
3
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Female, lethal 
♀  
0
0
;  $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
118 6715 Q4
ln4@ij,@ijB=k@ij
 Female, tubby body, 
unorganized eye 
pattern, missing end 
part of third vein, curly 
wings 
  Bui  
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♀  
0
0
;  $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
3
ln4@ij,@ijB=k@ij
 
 
Female, tubby body, 
missing end part of 
third vein, tubby body, 
unorganized eye patter 
♀  
0
0
;  $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
ln4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
 
Female, lethal 
♀  
0
0
;  Q
2;3LR6?7QR6d,=BefQ?
1
 
P
 ; + ; 118 6715 Q4
P
 
Female, tubby body, 
unorganized eye 
pattern, full veins 
♀  
0
0
; Q
2;3LR6?7QR6d,=BefQ?
1
P
 ; + ; 118 6715 Q4
ln4@ij,@ijB=k@ij
 
Female, tubby body, 
unorganized eye 
pattern, curly wings, 
missing end part of 
third vein  
♀  
0
0
; Q
2;3LR6?7QR6d,=BefQ?
1
P
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Female, lethal 
♂  
0
C
;   $%	
    ',P
 $%	    ',PP
 ; + ; 118 6715 Q4
P
 
Male, black body,  
curved wings, full 
veins 
♂  
0
C
;   $%	
    ',P
 $%	    ',PP
 ; + ; 3
ln4@ij,@ijB=k@ij
 
Male, missing last part 
of third vein, black 
body, curved wings 
♂  
0
C
;  
 $%	    ',P
 $%	    ',PP
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Male, lethal 
♂ 
0
C
;   $%	
    ',P
3
 ; + ; 118 6715 Q4
ln4@ij,@ijB=k@ij
 
Male, missing end part 
of third vein, straight 
wings 
♂  
0
C
;   $%	
    ',P
3
 ; + ; 118 6715 Q4
P
 
Male, no black body, 
no curved wings, full 
veins 
♂  
0
C
;   $%	
    ',P
3
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Male, lethal 
♂  
0
C
;   Q
2;3LR6?7QR6d,=BefQ?
1
 
P
 ; + ; 118 6715 Q4
P
 
Male, tubby body, 
unorganized eye 
pattern, straight wings 
♂  
0
C
; Q
2;3LR6?7QR6d,=BefQ?
1
3
 ; + ; 118 6715 Q4
ln4@ij,@ijB=k@ij
 
Male, red eyes, tubby 
body, unorganized eye 
pattern curly wings, 
missing end part of 
third vein 
♂  
0
C
; Q
2;3LR6?7QR6d,=BefQ?
1
3
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Male, lethal 
♂  
0
C
;   $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
118 6715 Q4
ln4@ij,@ijB=k@ij
 
Male, tubby body, 
unorganized eye 
pattern, curly wings, 
missing last part of 
third vein 
  Bui  
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♂  
0
C
;  
 $%	    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
3
ln4@ij,@ijB=k@ij
 
 
Male, missing end part 
of third vein, tubby 
body, unorganized eye 
pattern, curly wings 
♂  
0
C
;   $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
ln4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
 
Male, lethal 
 
 
F4 to obtain homozygous mutant chd1 with one copy of mutant 118 E-10 C4 
 
 
♀  
0
0
;  $%	
    ',P
;,

 ; + ; P
_` !, !"#!
    H  ♂ 
0
C
;  $%	
   '
()*,+,-./,01
;+; 		I J	T (
_` !, !"#!
 
 
 
   ↓ 
 
Expected Progeny Genotype Expected Phenotype 
♀  
0
0
;  $%	
    ',P
 $%	    ',PP
 ; + ; 118 6710 ;4
P
 
Female, black body, 
curved wings, full 
veins 
♀  
0
0
;  $%	
    ',P
 $%	    ',PP
 ; + ; 3
ln4@ij,@ijB=k@ij
 
Female, missing end 
part of third vein, 
curved wings, black 
body, straight wings 
♀  
0
0
;  $%	
    ',P
 $%	    ',PP
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 Female, lethal 
♀  
0
0
;  $%	
    ',P
3
 ; + ; 118 6710 ;4
ln4@ij,@ijB=k@ij
 Female, straight wings, 
red eyes, missing end 
part of third vein 
♀  
0
0
;  $%	
    ',P
3
 ; + ; 118 6710 ;4
P
 Female, straight wings, 
full veins  
♀  
0
0
;  $%	
    ',P
3
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Female, lethal 
♀  
0
0
;  $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
118 6710 ;4
ln4@ij,@ijB=k@ij
 Female, tubby body, 
unorganized eye 
pattern, missing end 
part of third vein, curly 
wings 
♀  
0
0
;  $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
3
ln4@ij,@ijB=k@ij
 
 
Female, tubby 
body,missing end part 
of third vein, tubby 
body, unorganized eye 
patter 
♀  
0
0
;  $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
ln4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
 
Female, lethal 
  Bui  
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♀  
0
0
;  Q
2;3LR6?7QR6d,=BefQ?
1
 
P
 ; + ; 118 6710 ;4
P
 
Female, tubby body, 
unorganized eye 
pattern, full veins 
♀  
0
0
; Q
2;3LR6?7QR6d,=BefQ?
1
P
 ; + ; 118 6710 ;4
ln4@ij,@ijB=k@ij
 
Female, tubby body, 
unorganized eye 
pattern, curly wings, 
missing end part of 
third vein  
♀  
0
0
; Q
2;3LR6?7QR6d,=BefQ?
1
P
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Female, lethal 
♂  
0
C
;   $%	
    ',P
 $%	    ',PP
 ; + ; 118 6710 ;4
P
 
Male, black body,  
curved wings, full 
veins 
♂  
0
C
;   $%	
    ',P
 $%	    ',PP
 ; + ; 3
ln4@ij,@ijB=k@ij
 
Male, missing last part 
of third vein, black 
body, curved wings 
♂  
0
C
;  
 $%	    ',P
 $%	    ',PP
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Male, lethal 
♂ 
0
C
;   $%	
    ',P
3
 ; + ; 118 6710 ;4
ln4@ij,@ijB=k@ij
 
Male, missing end part 
of third vein, straight 
wings 
♂  
0
C
;   $%	
    ',P
3
 ; + ; 118 6710 ;4
P
 
Male, no black body, 
no curved wings, full 
veins 
♂  
0
C
;   $%	
    ',P
3
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Male, lethal 
♂  
0
C
;   Q
2;3LR6?7QR6d,=BefQ?
1
 
P
 ; + ; 118 6710 ;4
P
 
Male, tubby body, 
unorganized eye 
pattern, straight wings 
♂  
0
C
; Q
2;3LR6?7QR6d,=BefQ?
1
3
 ; + ; 118 6710 ;4
ln4@ij,@ijB=k@ij
 
Male, red eyes, tubby 
body, unorganized eye 
pattern curly wings, 
missing end part of 
third vein 
♂  
0
C
; Q
2;3LR6?7QR6d,=BefQ?
1
3
 ; + ; ln
4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
Male, lethal 
♂  
0
C
;   $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
118 6710 ;4
ln4@ij,@ijB=k@ij
 
Male, tubby body, 
unorganized eye 
pattern, curly wings, 
missing last part of 
third vein 
♂  
0
C
;  
 $%	    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
3
ln4@ij,@ijB=k@ij
 
 
Male, missing end part 
of third vein, tubby 
body, unorganized eye 
pattern, curly wings 
♂  
0
C
;   $%	
    ',P
Q2;3LR6?7QR6d,=BefQ?
1 ; + ; 
ln4@ij,@ijB=k@ij
ln4@ij,@ijB=k@ij
 
 
Male, lethal 
  Bui  
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